女性特异性因素与遗传风险对心脏代谢疾病的协同效应:一项队列研究
将女性特异性因素纳入风险评估模型可提高预测准确性,尤其对高遗传风险女性。
要点
- FSRS每增加1分,CMD风险升高24%,并与疾病进展和死亡持续相关。
- 女性特异性因素与遗传风险协同增加CMD风险(pInteraction<0.001)。
- 高女性特异性风险且高遗传风险组CMD风险较双低组增加243%。
核心结论
- 女性特异性健康因素显著贡献于CMD风险,并与遗传易感性存在交互作用。
- 将女性特异性因素纳入风险评估模型可提高预测准确性,尤其对高遗传风险女性。
研究设计与样本
- 构建女性特异性风险评分(FSRS,范围0-6分),分析其与CMD发生和进展的关联。
主要发现
- FSRS每增加1分与CMD风险升高24%相关,并与首次CMD、心脏代谢多病共存和死亡的进展持续相关。
- 女性特异性因素与遗传易感性协同增加CMD风险(pInteraction<0.001)。
- 与低女性特异性风险和低遗传风险组相比,高女性特异性风险和高遗传风险组CMD风险增加243%。
- FSRS对CMD有较高预测价值,尤其在高遗传风险组,并适度改善两种推荐心血管算法的性能。
临床怎么用
- 在女性心血管风险评估中应考虑纳入女性特异性因素(如早绝经、不良妊娠结局等)。
- 对高遗传风险女性,结合FSRS可能提升风险预测准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of female-specific factors in the occurrence and progression of cardiometabolic disease (CMD) across different genetic risks remains incompletely clear. This study aimed to comprehensively assess the association of female-specific factors with the occurrence and progression of CMD. METHODS: This was a prospective cohort study of 150 413 female individuals from the UK Biobank. The female-specific factors in this study included premature menopause, adverse pregnancy outcomes, early or late menarche, multiparity, infertility, use of oral contraceptive or hormone therapy and autoimmune diseases, and a weighted female-specific risk score (FSRS, ranging from 0 to 6) was constructed. We analysed the association of female-specific factors with the occurrence and progression of CMD across genetic risks. RESULTS: A total of 16 636 CMD events were documented after a median follow-up of 13.7 years. A one-point increase in FSRS was associated with a 24% higher risk of incident CMD, with persistent association with progression to first CMD, cardiometabolic multimorbidity and mortality. Female-specific factors and genetic susceptibility were synergistically associated with a higher risk of CMD (pInteraction<0.001). Compared with the group with low female-specific and genetic risks, the group with high female-specific and genetic risk had a 243% increased risk of CMD. FSRS had a relatively high predictive value for CMD, especially in the group with higher genetic risks, and modestly improved the performance of two recommended cardiovascular algorithms. Phenotypic ageing, inflammation, metabolic factors, renal function and oestradiol collectively explained 21.6% of the association between FSRS and CMD. CONCLUSIONS: Female-specific health factors significantly contribute to CMD risk and interact with genetic susceptibility. Incorporating these factors into risk assessment models could enhance predictive accuracy, particularly for women with high genetic risk.
引用
- Yin J, Li T, Yu Z, et al. Synergistic effects of female-specific conditions and genetic risk on cardiometabolic disease: a cohort study. Heart. 2025. PMID: 40139682. doi:10.1136/heartjnl-2024-325355
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。